Canadian cannabis producer Organigram Holdings says its net revenue hit C$12.4 million, up from C$2.4 million last year. The reason: the launch of recreational pot sales last fall.
Organigram says its sales during the three-month period ended Nov. 30 marked a record quarterly high and amounted to more than what the company has historically sold to medical patients in an entire year. Organigram also reported net income from continuing operations of $29.5 million, up from a net loss of $1.2 million a year ago.